Navigation path

Community Register of medicinal products

Community list of not active orphan medicinal products
WITHDRAWN  

Product information

Nolatrexed

EU orphan designation number: EU/3/03/165
Active ingredient: Nolatrexed
Indication: Treatment of hepatocellular carcinoma
Sponsor: Scirex Ltd.
256 Grays Inn Road, London WC1X 8LD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2003 Centralised Orphan - Designation EMEA/OD/032/03 (2003)3570 of 02/10/2003
22/03/2006 Centralised Orphan - Removal of orphan designation from Community Register -